Global Med Technologies(R)' Inlog Subsidiary Licensed EdgeTrack to 62 French Hospitals in 2008, Including 19 Hospitals in Q4 200
January 14 2009 - 9:00AM
PR Newswire (US)
Transfusion Service Software Confirms its Leading Position in
French Hospital Market with More Than 130 Installations DENVER,
Jan. 14 /PRNewswire-FirstCall/ -- Global Med Technologies(R), Inc.
("Global Med" or the "Company") (OTC:GLOB) (BULLETIN BOARD: GLOB) ,
an international e-Health, medical information technology company,
today announced that its subsidiary, Inlog, has licensed its
EgdeTrack* Transfusion Services Software (marketed as "Hemo
Serveur" in France) to nineteen additional hospitals during the
fourth quarter of 2008. (Logo:
http://www.newscom.com/cgi-bin/prnh/20040226/GLOBALMEDLOGO)
EdgeTrack Transfusion Management Software provides a complete
transfusion record, including patient information, pre and
post-transfusion data tracking, tracing of blood components and
comprehensive tracking of orders, making it easier for hospital
technicians to provide appropriate blood products for patients.
EdgeTrack's complete feature set and configurability will assist
each of these hospitals in meeting their diverse needs and improve
their processes. In Q4 of 2008, the following French healthcare
organizations chose Inlog for their blood traceability and
transfusion management: Hospices Civils de Lyon (4 hospitals),
Polyclinique de la Ligne Bleue (Epinal), Vienne Hospital, Dreux
Hospital, Centre Medical de Forcilles, Bourgoin Jallieu Hospital,
Tarare Hospital, Laval Hospital, Villefranche-sur-Saone Hospital,
CAPIO group (4 hospitals), Centre Anti-Cancer Paul Papin (Angers),
Aubenas Hospital, Oyonnax Hospital. These hospitals join the 43
other establishments that chose EdgeTrack last year, including 21
Assistance Publique - Hopitaux de Paris ("AP-HP") hospitals, one of
the largest healthcare information technology projects ever
undertaken in Europe. Since EdgeTrack was introduced into the
market in 1995 as "Hemo Serveur", it has become a leading hospital
transfusion and traceability information management system in
France with more than 130 licensed hospitals. EdgeTrack easily
connects with most laboratory information systems (LIS) and
hospital information systems (HIS). EdgeTrack interchanges data
with all major blood banking information systems including Inlog's
own EdgeBlood (which is installed in 100% of the French Blood
Establishment's "EFS" Blood Donor Centers). Will Willman, Senior
Vice President of Sales and Marketing EU/ME/Asia at Global Med
Technologies, commented, "We are very pleased to have such wide
French market acceptance of our transfusion software. EdgeTrack has
been steadily gaining market share, which is now approximately 50%
of the French public hospitals that have transfusion software
installed. EdgeTrack has become a de-facto standard for French
public hospitals that require a proven transfusion solution with
quality installation, training and support services. We look
forward to helping each of these hospitals continue to provide
excellent and advanced transfusion services to their physicians and
patients." About Global Med Technologies, Inc. Global Med
Technologies(R), Inc. is an international medical software company
which develops regulated and non-regulated products and services
for the healthcare industry. As a leading provider of blood and
laboratory systems and services, Global Med's products are deployed
in 20 countries and serve over 1,600 transfusion centers, blood
banks and laboratories. Global Med's domestic companies are
Wyndgate Technologies(R), a leader in software products and
services for donor centers and hospital transfusion services;
eDonor(R), which offers web-based donor relationship management
systems; and PeopleMed(TM), Inc., which implements cost-effective
software validation, consulting and compliance solutions to
hospitals and donor centers. Global Med's European subsidiary,
Inlog, SA, is a leading developer of donor center and transfusion
management systems as well as cellular therapy software, laboratory
information systems and quality assurance medical software systems
internationally. For more information about Global Med's products
and services, please call 800-996-3428 or visit
http://www.globalmedtech.com/. This news release may include
statements that constitute forward-looking statements, usually
containing the words "believe," "estimate," "project," "expects" or
similar expressions. These statements are made pursuant to the safe
harbor provisions of the Private Securities Litigation Reform Act
of 1995. Forward-looking statements inherently involve risks and
uncertainties that could cause actual results to differ materially
from the forward-looking statements. By making these
forward-looking statements, the Company undertakes no obligation to
update these statements for revisions or changes after the date of
this news release.
http://www.newscom.com/cgi-bin/prnh/20040226/GLOBALMEDLOGO
http://photoarchive.ap.org/ DATASOURCE: Global Med Technologies,
Inc. CONTACT: Michael I. Ruxin, M.D. of Global Med Technologies,
Inc., +1-303-238-2000, ; or Investors, Paul Holm, President of
portfolio pr, +1-212-888-4570, , for Global Med Technologies, Inc.
Web Site: http://www.globalmedtech.com/
Copyright